Preliminary data on WTX-124 provide compelling early evidence of dose-dependent biomarker and antitumor activity in patients with advanced or metastatic solid tumors relapsed or refractory to standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results